search Search
Small and intuitive

Insulin Pump

myLoop - Automated insulin delivery on the YpsoPump from your smartphone

YpsoPump insulin pump

The intuitive¹ insulin pump system

The YpsoPump insulin pump can be used in an adaptive automated insulin delivery system, which learns and adjusts according to your needs, when combined with the CamAPS FX app.** This feature requires the YpsoPump software version V05.00.52 or higher and a connected Dexcom G6 or Freestyle Libre 3 / Libre 3 Plus sensor.

Product specifications

Pump dimensions

7.8 × 4.6 × 1.6 cm

Weight

83 g (including battery and filled cartridge)

Touchscreen dimensions

4.1 × 1.6 cm
OLED touchscreen

Bolus types

Standard, extended, combination and blind bolus.
Stacked bolus possible.

Bolus setting range

0.1 U to 30.0 U

Basal rate increments

0.1 U, 0.5 U, 1.0 U and 2.0 U

Basal rate

2 profiles (A and B), freely programmable by the user.
Temporary basal rate available.

Basal rate setting range

0.00 U/h to 40.0 U/h

Basal rate increments

Range 0.02 U/h to 1.00 U/h: 0.01 U/h
Range 1.00 U/h to 2.00 U/h: 0.02 U/h
Range 2.00 U/h to 15.0 U/h: 0.1 U/h
Range 15.0 U/h to 40.0 U/h: 0.5 U/h

Battery

1.5 V alkaline battery (LR03), size AAA. Service life typically 30 days of average use (54 U/day; temperature 23 °C ± 2 °C) with activated Bluetooth® function.

Water protection classification

IPX8 according to EN 60529 (immersion to a depth of 1 m for up to 60 minutes).

Communication interface

Bluetooth® 4.0 Low Energy
2 400 to 2 483.5 MHz

Self-filled myPump+ Reservoir

1.6 ml (160 U)
100 U/ml, rapid-acting insulin analogue.
For information on compatible insulins visit: myPump+ Reservoir

legal-manufacturer
Legal manufacturer
mylife Diabetes Care AG, Lyssachstrasse 40, CH-3400 Burgdorf, Switzerland, CE0123
information
Consult Instructions for use
Consult the YpsoPump User Guide to use the YpsoPump System.
Simple and reliable self-medication

Our product portfolio

Insulin pumps and Automated Insulin Delivery (AID) systems can significantly improve glucose management, but they do not eliminate the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g., infusion set failure, pump occlusion, empty reservoir, or device malfunction) can quickly lead to ketosis and DKA — even if glucose levels are not very high. DKA is a serious and potentially life-threatening condition.

If you feel unwell, have persistent high glucose levels, or detect positive ketones, please contact your diabetes care team immediately and follow their guidance. Do not rely solely on the AID system to correct high glucose or clear ketones. Always confirm that insulin is being delivered, and use your backup insulin method (e.g., insulin injections or insulin pens) if needed.

Medical advice can only be provided by healthcare professionals. The information in this material is intended for general educational purposes and should not be interpreted as medical advice or used as a substitute for consultation with a qualified healthcare professional.